Hsp90	NN
regulation	NN
of	IN
fibroblast	NN
activation	NN
in	IN
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
severe	JJ
fibrotic	JJ
lung	NN
disease	NN
associated	VBN
with	IN
fibroblast	NN
activation	NN
that	WDT
includes	VBZ
excessive	JJ
proliferation	NN
,	,
tissue	NN
invasiveness	NN
,	,
myofibroblast	NN
transformation	NN
,	,
and	CC
extracellular	JJ
matrix	NN
(	(
ECM	NN
)	)
production	NN
.	.

To	TO
identify	VB
inhibitors	NNS
that	WDT
can	MD
attenuate	VB
fibroblast	NN
activation	NN
,	,
we	PRP
queried	VBD
IPF	NN
gene	NN
signatures	NNS
against	IN
a	DT
library	NN
of	IN
small-molecule-induced	JJ
gene-expression	NN
profiles	NNS
and	CC
identified	VBN
Hsp90	NN
inhibitors	NNS
as	IN
potential	JJ
therapeutic	JJ
agents	NNS
that	WDT
can	MD
suppress	VB
fibroblast	NN
activation	NN
in	IN
IPF	NN
.	.

Although	IN
Hsp90	NN
is	VBZ
a	DT
molecular	JJ
chaperone	NN
that	WDT
regulates	VBZ
multiple	JJ
processes	NNS
involved	VBN
in	IN
fibroblast	NN
activation	NN
,	,
it	PRP
has	VBZ
not	RB
been	VBN
previously	RB
proposed	VBN
as	IN
a	DT
molecular	JJ
target	NN
in	IN
IPF	NN
.	.

Here	RB
,	,
we	PRP
found	VBD
elevated	JJ
Hsp90	NN
staining	NN
in	IN
lung	NN
biopsies	NNS
of	IN
patients	NNS
with	IN
IPF	NN
.	.

Notably	RB
,	,
fibroblasts	NNS
isolated	VBN
from	IN
fibrotic	JJ
lesions	NNS
showed	VBD
heightened	VBN
Hsp90	NN
ATPase	NN
activity	NN
compared	VBN
with	IN
normal	JJ
fibroblasts	NNS
.	.

17-N-allylamino-17-demethoxygeldanamycin	NN
(	(
17-AAG	NN
)	)
,	,
a	DT
small-molecule	JJ
inhibitor	NN
of	IN
Hsp90	NN
ATPase	NN
activity	NN
,	,
attenuated	VBD
fibroblast	NN
activation	NN
and	CC
also	RB
TGF-b-driven	JJ
effects	NNS
on	IN
fibroblast	NN
to	TO
myofibroblast	NN
transformation	NN
.	.

The	DT
loss	NN
of	IN
the	DT
Hsp90AB	NN
,	,
but	CC
not	RB
the	DT
Hsp90AA	NN
isoform	NN
,	,
resulted	VBD
in	IN
reduced	VBN
fibroblast	NN
proliferation	NN
,	,
myofibroblast	NN
transformation	NN
,	,
and	CC
ECM	NN
production	NN
.	.

Finally	RB
,	,
in	FW
vivo	FW
therapy	NN
with	IN
17-AAG	NN
attenuated	VBD
progression	NN
of	IN
established	JJ
and	CC
ongoing	JJ
fibrosis	NN
in	IN
a	DT
mouse	NN
model	NN
of	IN
pulmonary	JJ
fibrosis	NN
,	,
suggesting	VBG
that	IN
targeting	VBG
Hsp90	NN
represents	VBZ
an	DT
effective	JJ
strategy	NN
for	IN
the	DT
treatment	NN
of	IN
fibrotic	JJ
lung	NN
disease	NN
.	.

